|
|
||||||||

,
*
Department of Rheumatology, Hospital for Joint Diseases, New York, NY 10003; and Departments of
Medicine and
Pathology, Kaplan Cancer Center, New York University Medical Center, New York, NY 10016.
Murine macrophages (RAW 264.7) when stimulated with LPS show 90%
distribution of cyclooxygenase-2 (COX-2) in the nuclear fraction and
10% in the cytosolic fraction. Further analysis of this cytosolic
fraction at 100,000 x g indicates that the COX-2
is distributed both in the 100,000 x g soluble
fraction and membrane fraction. Stimulation of RAW 264.7 cells with LPS
in the presence of inducible nitric oxide synthase inhibitor
L-NMMA at concentrations that inhibit nitrite accumulation
by
80% is inadequate to augment PGE2 production.
However, inhibition of nitrite accumulation by
85% with higher
concentrations of L-NMMA shows 1) up-regulation of
PGE2 production, 2) accumulation of COX-2 protein in the
100,000 x g soluble and membrane fractions of the
cytosolic fraction, and 3) with no significant effects on the
accumulation of COX-2 mRNA. These experiments suggest that low
concentrations of nitric oxide (1015% of the total) attenuate
PGE2 production in response to LPS in RAW 264.7 cells. This
inhibition is, in part, due to decreased expression of cytosolic COX-2
protein.
This article has been cited by other articles:
![]() |
M. Yamashita, T. Shinohara, S. Tsuji, Q. N. Myrvik, A. Nishiyama, R. A. Henriksen, and Y. Shibata Catalytically Inactive Cyclooxygenase 2 and Absence of Prostaglandin E2 Biosynthesis in Murine Peritoneal Macrophages following In Vivo Phagocytosis of Heat-Killed Mycobacterium bovis Bacillus Calmette-Guerin J. Immunol., November 15, 2007; 179(10): 7072 - 7078. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamashita, S. Tsuji, A. Nishiyama, Q. N. Myrvik, R. A. Henriksen, and Y. Shibata Differential subcellular localization of COX-2 in macrophages phagocytosing heat-killed Mycobacterium bovis BCG Am J Physiol Cell Physiol, July 1, 2007; 293(1): C184 - C190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kapoor, F. Kojima, M. Qian, L. Yang, and L. J. Crofford Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis FASEB J, November 1, 2006; 20(13): 2387 - 2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Connelly, A. T. Jacobs, M. Palacios-Callender, S. Moncada, and A. J. Hobbs Macrophage Endothelial Nitric-oxide Synthase Autoregulates Cellular Activation and Pro-inflammatory Protein Expression J. Biol. Chem., July 11, 2003; 278(29): 26480 - 26487. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Q. Zhou, Y.-Q. Chen, J. H. Fisher, and M.-H. Wang Activation of the RON Receptor Tyrosine Kinase by Macrophage-stimulating Protein Inhibits Inducible Cyclooxygenase-2 Expression in Murine Macrophages J. Biol. Chem., October 4, 2002; 277(41): 38104 - 38110. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bolli, K. Shinmura, X.-L. Tang, E. Kodani, Y.-T. Xuan, Y. Guo, and B. Dawn Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning Cardiovasc Res, August 15, 2002; 55(3): 506 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinmura, Y.-T. Xuan, X.-L. Tang, E. Kodani, H. Han, Y. Zhu, and R. Bolli Inducible Nitric Oxide Synthase Modulates Cyclooxygenase-2 Activity in the Heart of Conscious Rabbits During the Late Phase of Ischemic Preconditioning Circ. Res., March 22, 2002; 90(5): 602 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Prokopczyk, N. Trushin, J. Leszczynska, S. E. Waggoner, and K. El-Bayoumy Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via {{alpha}}-hydroxylation and carbonyl reduction pathways Carcinogenesis, January 1, 2001; 22(1): 107 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Giroux and A. Descoteaux Cyclooxygenase-2 Expression in Macrophages: Modulation by Protein Kinase C-{alpha} J. Immunol., October 1, 2000; 165(7): 3985 - 3991. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Clancy, B. Varenika, W. Huang, L. Ballou, M. Attur, A. R. Amin, and S. B. Abramson Nitric Oxide Synthase/COX Cross-Talk: Nitric Oxide Activates COX-1 But Inhibits COX-2-Derived Prostaglandin Production J. Immunol., August 1, 2000; 165(3): 1582 - 1587. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Reilly, J. C. Oates, J. A. Cook, J. D. Morrow, P. V. Halushka, and G. S. Gilkeson Inhibition of Mesangial Cell Nitric Oxide in MRL/lpr Mice by Prostaglandin J2 and Proliferator Activation Receptor-{gamma} Agonists J. Immunol., February 1, 2000; 164(3): 1498 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Patel, M. G. Attur, M. N. Dave, I. V. Patel, S. A. Stuchin, S. B. Abramson, and A. R. Amin A Novel Mechanism of Action of Chemically Modified Tetracyclines: Inhibition of COX-2-Mediated Prostaglandin E2 Production J. Immunol., September 15, 1999; 163(6): 3459 - 3467. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinmura, Y.-T. Xuan, X.-L. Tang, E. Kodani, H. Han, Y. Zhu, and R. Bolli Inducible Nitric Oxide Synthase Modulates Cyclooxygenase-2 Activity in the Heart of Conscious Rabbits During the Late Phase of Ischemic Preconditioning Circ. Res., March 22, 2002; 90(5): 602 - 608. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |